Skip to content
Loop Biz – Lifestyle
Author:
Viatris Inc.
Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
September 16, 2026
Viatris Reports Second-Quarter 2026 Financial Results
August 6, 2026
Viatris Announces Quarterly Dividend
August 4, 2026
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
July 1, 2026
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
June 29, 2026